The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Esomeprazole Magnesium Enteric-coated Capsules Market Research Report 2024
Synopsis
Global Esomeprazole Magnesium Enteric-coated Capsules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Esomeprazole Magnesium Enteric-coated Capsules market research.
Key manufacturers engaged in the Esomeprazole Magnesium Enteric-coated Capsules industry include Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., CSPC Pharmaceutical Group Limited, AstraZeneca, Zhejiang Huahai Pharmaceutical Co., Ltd., Cisen Pharmaceutical Co., Ltd., Sunshine Lake Pharma Co., Ltd., Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd. and DM Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Esomeprazole Magnesium Enteric-coated Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Esomeprazole Magnesium Enteric-coated Capsules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Esomeprazole Magnesium Enteric-coated Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
CSPC Pharmaceutical Group Limited
AstraZeneca
Zhejiang Huahai Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Sunshine Lake Pharma Co., Ltd.
Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
DM Pharma
Dr. Reddy
Actoverco Pharmaceutical
Aristopharma Ltd
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Esomeprazole Magnesium Enteric-coated Capsules report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Esomeprazole Magnesium Enteric-coated Capsules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Esomeprazole Magnesium Enteric-coated Capsules market research.
Key manufacturers engaged in the Esomeprazole Magnesium Enteric-coated Capsules industry include Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., CSPC Pharmaceutical Group Limited, AstraZeneca, Zhejiang Huahai Pharmaceutical Co., Ltd., Cisen Pharmaceutical Co., Ltd., Sunshine Lake Pharma Co., Ltd., Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd. and DM Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Esomeprazole Magnesium Enteric-coated Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Esomeprazole Magnesium Enteric-coated Capsules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Esomeprazole Magnesium Enteric-coated Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
CSPC Pharmaceutical Group Limited
AstraZeneca
Zhejiang Huahai Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Sunshine Lake Pharma Co., Ltd.
Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
DM Pharma
Dr. Reddy
Actoverco Pharmaceutical
Aristopharma Ltd
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Esomeprazole Magnesium Enteric-coated Capsules report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Esomeprazole Magnesium Enteric-coated Capsules Market Overview
1.1 Product Overview and Scope of Esomeprazole Magnesium Enteric-coated Capsules
1.2 Esomeprazole Magnesium Enteric-coated Capsules Segment by Type
1.2.1 Global Esomeprazole Magnesium Enteric-coated Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Esomeprazole Magnesium Enteric-coated Capsules Segment by Application
1.3.1 Global Esomeprazole Magnesium Enteric-coated Capsules Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Esomeprazole Magnesium Enteric-coated Capsules Market Size Estimates and Forecasts
1.4.1 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue 2018-2029
1.4.2 Global Esomeprazole Magnesium Enteric-coated Capsules Sales 2018-2029
1.4.3 Global Esomeprazole Magnesium Enteric-coated Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Esomeprazole Magnesium Enteric-coated Capsules Market Competition by Manufacturers
2.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Esomeprazole Magnesium Enteric-coated Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Esomeprazole Magnesium Enteric-coated Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Esomeprazole Magnesium Enteric-coated Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Esomeprazole Magnesium Enteric-coated Capsules, Product Type & Application
2.7 Esomeprazole Magnesium Enteric-coated Capsules Market Competitive Situation and Trends
2.7.1 Esomeprazole Magnesium Enteric-coated Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Esomeprazole Magnesium Enteric-coated Capsules Players Market Share by Revenue
2.7.3 Global Esomeprazole Magnesium Enteric-coated Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Esomeprazole Magnesium Enteric-coated Capsules Retrospective Market Scenario by Region
3.1 Global Esomeprazole Magnesium Enteric-coated Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Esomeprazole Magnesium Enteric-coated Capsules Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Region: 2018-2029
3.2.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Region: 2018-2023
3.2.2 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Region: 2024-2029
3.3 Global Esomeprazole Magnesium Enteric-coated Capsules Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Region: 2018-2029
3.3.1 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Region: 2018-2023
3.3.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Region: 2024-2029
3.4 North America Esomeprazole Magnesium Enteric-coated Capsules Market Facts & Figures by Country
3.4.1 North America Esomeprazole Magnesium Enteric-coated Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Esomeprazole Magnesium Enteric-coated Capsules Sales by Country (2018-2029)
3.4.3 North America Esomeprazole Magnesium Enteric-coated Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Esomeprazole Magnesium Enteric-coated Capsules Market Facts & Figures by Country
3.5.1 Europe Esomeprazole Magnesium Enteric-coated Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Esomeprazole Magnesium Enteric-coated Capsules Sales by Country (2018-2029)
3.5.3 Europe Esomeprazole Magnesium Enteric-coated Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Esomeprazole Magnesium Enteric-coated Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Esomeprazole Magnesium Enteric-coated Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Esomeprazole Magnesium Enteric-coated Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Esomeprazole Magnesium Enteric-coated Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Esomeprazole Magnesium Enteric-coated Capsules Market Facts & Figures by Country
3.7.1 Latin America Esomeprazole Magnesium Enteric-coated Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Esomeprazole Magnesium Enteric-coated Capsules Sales by Country (2018-2029)
3.7.3 Latin America Esomeprazole Magnesium Enteric-coated Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Esomeprazole Magnesium Enteric-coated Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Esomeprazole Magnesium Enteric-coated Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Esomeprazole Magnesium Enteric-coated Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Esomeprazole Magnesium Enteric-coated Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Type (2018-2029)
4.1.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Type (2018-2023)
4.1.2 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Type (2024-2029)
4.1.3 Global Esomeprazole Magnesium Enteric-coated Capsules Sales Market Share by Type (2018-2029)
4.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Type (2018-2029)
4.2.1 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Type (2018-2023)
4.2.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Type (2024-2029)
4.2.3 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Esomeprazole Magnesium Enteric-coated Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Application (2018-2029)
5.1.1 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Application (2018-2023)
5.1.2 Global Esomeprazole Magnesium Enteric-coated Capsules Sales by Application (2024-2029)
5.1.3 Global Esomeprazole Magnesium Enteric-coated Capsules Sales Market Share by Application (2018-2029)
5.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Application (2018-2029)
5.2.1 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Application (2018-2023)
5.2.2 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue by Application (2024-2029)
5.2.3 Global Esomeprazole Magnesium Enteric-coated Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Esomeprazole Magnesium Enteric-coated Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
6.1.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.1.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 CSPC Pharmaceutical Group Limited
6.2.1 CSPC Pharmaceutical Group Limited Corporation Information
6.2.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.2.3 CSPC Pharmaceutical Group Limited Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSPC Pharmaceutical Group Limited Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.2.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AstraZeneca Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Zhejiang Huahai Pharmaceutical Co., Ltd.
6.4.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.4.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Cisen Pharmaceutical Co., Ltd.
6.5.1 Cisen Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Cisen Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Cisen Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cisen Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.5.5 Cisen Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Sunshine Lake Pharma Co., Ltd.
6.6.1 Sunshine Lake Pharma Co., Ltd. Corporation Information
6.6.2 Sunshine Lake Pharma Co., Ltd. Description and Business Overview
6.6.3 Sunshine Lake Pharma Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sunshine Lake Pharma Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.6.5 Sunshine Lake Pharma Co., Ltd. Recent Developments/Updates
6.7 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd.
6.6.1 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd. Corporation Information
6.6.2 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.7.5 Hainan Huipusen Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
6.8 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
6.8.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
6.8.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.8.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 DM Pharma
6.9.1 DM Pharma Corporation Information
6.9.2 DM Pharma Description and Business Overview
6.9.3 DM Pharma Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 DM Pharma Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.9.5 DM Pharma Recent Developments/Updates
6.10 Dr. Reddy
6.10.1 Dr. Reddy Corporation Information
6.10.2 Dr. Reddy Description and Business Overview
6.10.3 Dr. Reddy Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dr. Reddy Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.10.5 Dr. Reddy Recent Developments/Updates
6.11 Actoverco Pharmaceutical
6.11.1 Actoverco Pharmaceutical Corporation Information
6.11.2 Actoverco Pharmaceutical Esomeprazole Magnesium Enteric-coated Capsules Description and Business Overview
6.11.3 Actoverco Pharmaceutical Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Actoverco Pharmaceutical Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.11.5 Actoverco Pharmaceutical Recent Developments/Updates
6.12 Aristopharma Ltd
6.12.1 Aristopharma Ltd Corporation Information
6.12.2 Aristopharma Ltd Esomeprazole Magnesium Enteric-coated Capsules Description and Business Overview
6.12.3 Aristopharma Ltd Esomeprazole Magnesium Enteric-coated Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aristopharma Ltd Esomeprazole Magnesium Enteric-coated Capsules Product Portfolio
6.12.5 Aristopharma Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Esomeprazole Magnesium Enteric-coated Capsules Industry Chain Analysis
7.2 Esomeprazole Magnesium Enteric-coated Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Esomeprazole Magnesium Enteric-coated Capsules Production Mode & Process
7.4 Esomeprazole Magnesium Enteric-coated Capsules Sales and Marketing
7.4.1 Esomeprazole Magnesium Enteric-coated Capsules Sales Channels
7.4.2 Esomeprazole Magnesium Enteric-coated Capsules Distributors
7.5 Esomeprazole Magnesium Enteric-coated Capsules Customers
8 Esomeprazole Magnesium Enteric-coated Capsules Market Dynamics
8.1 Esomeprazole Magnesium Enteric-coated Capsules Industry Trends
8.2 Esomeprazole Magnesium Enteric-coated Capsules Market Drivers
8.3 Esomeprazole Magnesium Enteric-coated Capsules Market Challenges
8.4 Esomeprazole Magnesium Enteric-coated Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
